Coley's toxins in perspective.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 1574121.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite initial hopes, the efficacy of tumour necrosis factor in treating cancer patients has been disappointing. But a more careful selection of patients, and more appropriate treatment, might be fruitful.
Medical subject headings
- Bacterial Vaccines
- Sarcoma
- Soft Tissue Neoplasms